SCHEMBL2482843

SCHEMBL2482843

CCc1cc(C(C)(C)CC(C)(C)C)cc(OC(=O)c2ccccc2)c1OC(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.41
MAPT P10636 4/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 3/20 0.39
POLB P06746 2/20 0.39
GAA P10253 1/20 0.39
SLC6A3 Q01959 1/20 0.38
MEN1 O00255 2/20 0.37
CYP3A4 P08684 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MDH1 P40925 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2888400 0.92 NPSR1 (0.41) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2507012 0.90 NPSR1 (0.40) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2888081 0.89 NPSR1 (0.38) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2886891 0.88 KMT2A (0.43) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2510166 0.87 MAPT (0.51) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2888364 0.84 MAPT (0.40) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2506912 0.83 MAPT (0.40) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2508302 0.81 TDP1 (0.49) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2512726 0.80 KMT2A (0.38) KMT2AMAPTSMN1; SMN2NPSR1TDP1
SCHEMBL2478898 0.79 NPSR1 (0.50) KMT2AMAPTSMN1; SMN2NPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT KMT2A 1611/4885MAPT 2384/4885SMN1; SMN2 4422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.